Page last updated: 2024-08-24

emtricitabine and Fibrosis

emtricitabine has been researched along with Fibrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrero, A; Collado, A; de Lagarde-Sebastián, M; Delgado-Fernández, M; Espinosa, N; Gómez-Berrocal, A; Hernández-Quero, J; Hontañón-Antoñana, V; Jiménez-Aguilar, P; Macías, J; Merino, D; Neukam, K; Pérez-Camacho, I; Pineda, JA; Ríos, MJ; Rivero-Juárez, A; Ruiz-Morales, J; Téllez, F; Vera-Méndez, F	1

Other Studies

1 other study(ies) available for emtricitabine and Fibrosis

Article	Year
Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. PloS one, 2016, Volume: 11, Issue:5 Topics: Adult; Anti-Retroviral Agents; Antiviral Agents; Bilirubin; Case-Control Studies; Coinfection; Drug Therapy, Combination; Emtricitabine; Female; Fibrosis; Hepacivirus; Hepatitis C; HIV Infections; Hospitalization; Humans; Liver; Male; Middle Aged; Retrospective Studies; Rilpivirine; Spain; Tablets; Tenofovir; Transaminases	2016

Article

Year

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study.

PloS one, 2016, Volume: 11, Issue:5

Topics: Adult; Anti-Retroviral Agents; Antiviral Agents; Bilirubin; Case-Control Studies; Coinfection; Drug Therapy, Combination; Emtricitabine; Female; Fibrosis; Hepacivirus; Hepatitis C; HIV Infections; Hospitalization; Humans; Liver; Male; Middle Aged; Retrospective Studies; Rilpivirine; Spain; Tablets; Tenofovir; Transaminases

2016